Home   /   Taxonomy   /   Term

Enleofen Bio

Healthcare

Boehringer Ingelheim to acquire assets, IP from Singapore biotech firm in deal worth more than US$1 bil

The deal is the largest for any biotech company in Singapore, and among the biggest globally for preclinical stage programmes.
×